• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Swiss company manufactured the drug raises the duration of validity of 5 to 7 years

Re: Swiss company manufactured the drug raises the duration of validity of 5 to 7 years

"Swiss company manufactured the drug raises the duration of validity of 5 to 7 years"
#1:...


Hopefully it would work.

As I previously posted, first it was a 2 years timeline.

After it was upgraded to 5 years.

Than, because 2+5=7, now it is good for 7 years.

The above demonstrated that the situation is rapidly evolving,
and there will be no easy big numbers answers.
 
Re: Swiss company manufactured the drug raises the duration of validity of 5 to 7 years

I had a hard time understanding that article (what's new, eh? :D)

Are they just pulling the drug until the extension is officially approved?

I found this:

EMEA extends shelf-life of Tamiflu as swine flu spreads

The European Medicines Agency (EMEA) has extended its authorisation for using Tamiflu, as swine flu continues to spread.

It has recommended that the shelf life of Tamiflu capsules be extended from five to seven years. This will formally apply to newly manufactured Tamiflu capsules and EMEA has also recommended that capsules already on sale be sold for two years beyond their current five-year expiry date, should the World Health Organisation (WHO) declare a pandemic.

Also, in such circumstances, EMEA said patients who have Tamiflu capsules that have recently expired should not dispose of them.

The agency has also advised that after a WHO pandemic declaration, Tamiflu should be used to treat babies under one-year-old plus pregnant or breast-feeding women, sweeping away earlier official cautions.

http://www.manufacturingchemist.com/story.asp?sectioncode=109&storycode=55769&c=1
 
You must log in or register to reply here.
Back
Top Bottom